规格

价格

库存

数量

1 mg

¥ 891

现货

5 mg

¥ 2,320

现货

10 mg

¥ 3,580

现货

25 mg

¥ 5,890

现货

50 mg

¥ 8,000

现货

100 mg

¥ 10,600

现货

200 mg

¥ 14,100

现货

生物活性

产品描述	NX-2127 (ETX2514 Triethylamine) is an orally active BTK inhibitor that induces degradation of mutant BTKC481S in cells.NX-2127 has potent antiproliferative activity and inhibits the proliferation of BTKC481S mutant TMD8 cells.NX-2127 potently catalyzes the degradation of Ikaros (IKZF1) and Aiolos (IKZF3) at 25 nM and 54 nM, respectively. NX-2127 is associated with the immune system, stimulating T cell activation and increasing IL-2 production in primary human T cells.
体外活性	NX-2127 inhibits the proliferation of BTK-C481S mutant TMD8 cells with an EC50 value of <30 nM.[1] NX-2127 increases IL-2 production in primary human T cells.[1]
体内活性	NX-2127 (1 mg/kg; oral; once daily for 14 days) showed efficient degradation of BTK in cynomolgus monkeys.[1] NX-2127 (oral administration) results in dose-proportional exposure and degradation of BTK in plasma to less than 10% of baseline levels in circulating and splenic B cells.[1] NX-2127 produces superior tumor growth inhibition (TGI) in WT TMD8 and C481S mutant xenograft models in mice.[1]
别名	NX2127, NX 2127

化学信息

分子量	719.83
分子式	C₃₉H₄₅N₉O₅
CAS No.	2416131-46-7
Smiles	O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=C(C2)N4C[C@H](CN5CCC(CC5)C6=CC=C(NC=7C(C(N)=O)=NC=C(N7)N8CCCCC8)C=C6)CC4

储存&溶解度

存储

keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

溶解度信息

DMSO: 150 mg/mL (208.38 mM), Sonication is recommended.

体内实验配方

2% DMSO+40% PEG300+5% Tween 80+53% Saline: 3 mg/mL (4.17 mM), Suspension.

请按顺序添加溶剂，在添加下一种溶剂之前，尽可能使溶液澄清。如有必要，可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考，体内配方并不是绝对的，请根据不同情况进行调整。

溶液配制表

DMSO